Brain tissue changes and antipsychotic medication

Expert Review of Neurotherapeutics

Volumn 11, Issue 7, 2011, Pages 943-946

  Puri, Basant K ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

atypical antipsychotic medication; brain changes; MRI; schizophrenia; typical antipsychotic medication

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; HALOPERIDOL; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ARTICLE; BRAIN REGION; BRAIN SIZE; BRAIN TISSUE; COGNITIVE THERAPY; DISEASE DURATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; HUMAN; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUBSTANCE ABUSE;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; HUMANS; SCHIZOPHRENIA;

EID: 79959928068     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.87     Document Type: Article

References (20)

1. Insel TR. Rethinking schizophrenia. Nature 468(7321), 187-193 (2010).
2. Puri BK. Progressive structural brain changes in schizophrenia. Expert Rev. Neurother. 10(1), 33-42 (2010).
3. Taylor S, Christensen JD, Holcomb JM, Garver DL. Volume increases in striatum associated with positive symptom reduction in schizophrenia: a preliminary observation. Psychiatry Res. 140(1), 85-89 (2005). (Pubitemid 41443499)
4. Thompson PM, Bartzokis G, Hayashi KM et al. Time-lapse mapping of cortical changes in schizophrenia with different treatments. Cereb. Cortex 19(5), 1107-1123 (2009).
5. Hulshoff Pol HE, Kahn RS. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr. Bull. 34(2), 354-366 (2008). (Pubitemid 351323347)
6. Smieskova R, Fusar-Poli P, Allen P et al. The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia? - A systematic review. Curr. Pharm. Des. 15(22), 2535-2549 (2009).
7. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch. Gen. Psychiatry 68(2), 128-137 (2011
8. Dorph-Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30(9), 1649-1661 (2005 (Pubitemid 43086022)
9. Konopaske GT, Dorph-Petersen KA, Pierri JN, Wu Q, Sampson AR, Lewis DA. Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology 32(6), 1216-1223 (2007). (Pubitemid 46788845)
10. Konopaske GT, Dorph-Petersen KA, Sweet RA et al. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol. Psychiatry 63(8), 759-765 (2008). (Pubitemid 351400762)
11. Harrison PJ, Lewis DA. Neuropathology of schizophrenia. In:Schizophrenia, 2nd Edition. Hirsch SR, Weinberger DR (Eds). Blackwell Science, Oxford, UK, 310-325 (2003).
12. Lewis DA. Antipsychotic medications and brain volume: do we have cause for concern? Arch. Gen. Psychiatry 68(2), 126-127 (2011).
13. Sweet RA, Henteleff RA, Zhang W, Sampson AR, Lewis DA. Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology 34(2), 374-389 (2009).
14. Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol. Psychiatry 67(3), 255-262 (2010).
15. Davis JM. Dose equivalence of the antipsychotic drugs. J. Psychiatr. Res. 11, 65-69 (1974).
16. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 33(6), 766-771 (1976).
17. Gogtay N, Giedd JN, Lusk L et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc. Natl Acad. Sci. USA 101(21), 8174-8179 (2004). (Pubitemid 38698073)
18. Abbott A. Schizophrenia: the drug deadlock. Nature 468(7321), 158-159 (2010).
19. Lieberman JA, Stroup TS, McEvoy JP et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 353(12), 1209-1223 (2005). (Pubitemid 41345943)
20. Wykes T. Cognitive remediation therapy needs funding. Nature 468(7321), 165-166 (2010).